MIT Libraries logoDSpace@MIT

MIT
View Item 
  • DSpace@MIT Home
  • MIT Open Access Articles
  • MIT Open Access Articles
  • View Item
  • DSpace@MIT Home
  • MIT Open Access Articles
  • MIT Open Access Articles
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Antibody Derived Peptides for Detection of Ebola Virus Glycoprotein

Author(s)
Rodriguez-Martinez, Luis Mario; Marquez-Ipina, Alan Roberto; Lopez-Pacheco, Felipe; Perez-Chavarria, Roberto; Gonzalez-Vazquez, Juan Carlos; Gonzalez-Gonzalez, Everardo; Trujillo-de Santiago, Grissel; Ponce-Ponce de Leon, Cesar Alejandro; Zhang, Yu Shrike; Dokmeci, Mehmet Remzi; Khademhosseini, Ali; Alvarez, Mario Moises; ... Show more Show less
Thumbnail
DownloadRodriguez-Martinez-2015-Antibody Derived Pep.pdf (5.438Mb)
PUBLISHER_CC

Publisher with Creative Commons License

Creative Commons Attribution

Terms of use
Creative Commons Attribution http://creativecommons.org/licenses/by/4.0/
Metadata
Show full item record
Abstract
Background Current Ebola virus (EBOV) detection methods are costly and impractical for epidemic scenarios. Different immune-based assays have been reported for the detection and quantification of Ebola virus (EBOV) proteins. In particular, several monoclonal antibodies (mAbs) have been described that bind the capsid glycoprotein (GP) of EBOV GP. However, the currently available platforms for the design and production of full-length mAbs are cumbersome and costly. The use of antibody fragments, rather than full-length antibodies, might represent a cost-effective alternative for the development of diagnostic and possibly even therapeutic alternatives for EBOV. Methods/Principal Findings We report the design and expression of three recombinant anti-GP mAb fragments in Escherichia coli cultures. These fragments contained the heavy and light variable portions of the three well-studied anti-GP full-length mAbs 13C6, 13F6, and KZ52, and are consequently named scFv-13C6, scFv-13F6, and Fab-KZ52, respectively. All three fragments exhibited specific anti-GP binding activity in ELISA experiments comparable to that of full-length anti-GP antibodies (i.e., the same order of magnitude) and they are easily and economically produced in bacterial cultures. Conclusion/Significance Antibody fragments might represent a useful, effective, and low cost alternative to full-length antibodies in Ebola related capture and diagnostics applications.
Date issued
2015-10
URI
http://hdl.handle.net/1721.1/99735
Department
Harvard University--MIT Division of Health Sciences and Technology
Journal
PLOS ONE
Publisher
Public Library of Science
Citation
Rodriguez-Martinez, Luis Mario, Alan Roberto Marquez-Ipina, Felipe Lopez-Pacheco, Roberto Perez-Chavarria, Juan Carlos Gonzalez-Vazquez, Everardo Gonzalez-Gonzalez, Grissel Trujillo-de Santiago, et al. “Antibody Derived Peptides for Detection of Ebola Virus Glycoprotein.” Edited by Gourapura J Renukaradhya. PLoS ONE 10, no. 10 (October 21, 2015): e0135859.
Version: Final published version
ISSN
1932-6203

Collections
  • MIT Open Access Articles

Browse

All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

My Account

Login

Statistics

OA StatisticsStatistics by CountryStatistics by Department
MIT Libraries
PrivacyPermissionsAccessibilityContact us
MIT
Content created by the MIT Libraries, CC BY-NC unless otherwise noted. Notify us about copyright concerns.